Bio-Rad Laboratories Inc (BIO)
Net profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -637,300 | -3,627,500 | 4,254,260 | 3,814,230 | 1,758,700 |
| Revenue | US$ in thousands | 5,298,670 | 5,562,940 | 5,851,740 | 5,058,790 | 4,601,000 |
| Net profit margin | -12.03% | -65.21% | 72.70% | 75.40% | 38.22% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $-637,300K ÷ $5,298,670K
= -12.03%
The net profit margin of Bio-Rad Laboratories Inc. has exhibited significant fluctuations over the past five years. In 2023, the company's net profit margin was -23.86%, which indicates that the company incurred a loss equivalent to 23.86% of its total revenues. This negative profit margin suggests that the company's expenses exceeded its revenues for that period.
The sharp decrease in net profit margin from 2022 (-129.45%) to 2023 (-23.86%) indicates that the company was able to reduce its loss significantly within one year. However, the negative figure still signifies that the company was not able to generate profits during 2023.
Conversely, in 2021 and 2020, Bio-Rad Laboratories Inc. exhibited exceptionally high net profit margins of 145.28% and 149.52% respectively. These figures imply that the company's profits far exceeded its total revenues during those years, suggesting high efficiency in cost management and revenue generation.
The net profit margin of 76.08% in 2019 indicates a solid profitability performance for Bio-Rad Laboratories Inc. during that year.
In summary, Bio-Rad Laboratories Inc. has experienced drastic fluctuations in its net profit margins over the past five years, with both highly profitable and loss-making periods. Analyzing the factors driving these fluctuations, such as changes in revenue, expenses, and overall business performance, would provide valuable insights into the financial health and operational efficiency of the company.
Peer comparison
Dec 31, 2023